Stentssms&FUSNCT01172158
SMS Reminder for Forgotten Ureteral Stents
An observational study of Stents, run by Dicle University at 1 site in Turkey (Türkiye).
Trial summary
Ureteral stents has become an indispensable instrument for urology practice as a result of widespread use of endourological interventions. Removal of stents could be sometimes neglected by patients or physicians. Read more about this study
- Who is it for?
- Ages 1 year to 80 years
- Conditions the study is for
- Stents
- How many people
- 250 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- May 2010to Aug 2011
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 year to 80 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: First an institutional subscription agreement was signed between our university and a mobile phone cell company which is supporting SMS sending program. In the By making software plug-in to our hospital's patient follow up program, two programs were integrated. According to this integration, after stent insertion, in case of entering the numerical code corresponding of ''ureteral stent application'' procedure during the stage of epicrisis preparation, the patient follow up system warns the official recording the epicrisis to enter the stent removal time. Patient follow up system transfers this information to SMS sending program. After several weeks of the procedure, if the stent needs to be removed, the software automatically sends a warning message to the patient and the physician.
Who may be able to join
- Patients who had ureteral stent insertion.
Who cannot join
- Patients who did not want SMS message from us or want to give cell phone number.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Dicle University School of Medicine
Diyarbakır
About this study
Official title: A Solution for Medical and Legal Problems Arising From Forgotten Ureteral Stents: Reminder Short Message Service (SMS)
Ureteral stents has become an indispensable instrument for urology practice as a result of widespread use of endourological interventions. Removal of stents could be sometimes neglected by patients or physicians. This omission may lead to legal and medical problems for urologists, health institutions and also for patients. In this study, the investigators offer a computer program providing two sided recall to prevent this nasty complication with sending automatic message by short message service (SMS) to both the patient and the urologist.
Read the detailed description
In this study, first an institutional subscription agreement was signed between our university and a mobile phone cell company which is supporting SMS sending program. In the second step, by making software plug-in to our hospital's patient follow up program, two programs were integrated. According to this integration, after stent insertion, in case of entering the numerical code corresponding of ''ureteral stent application'' procedure during the stage of epicrisis preparation, the patient follow up system warns the official recording the epicrisis to enter the stent removal time. Patient follow up system transfers this information to SMS sending program. After several weeks of the procedure, if the stent needs to be removed, the software automatically sends a warning message to the patient and the physician. If the patients attends to urology department and undergoes stent removal, the official enters the code of "endoscopic stent removal" to the patient follow-up program. Then the program stops to send warning message.
By the software plug-in to patient follow up program, SMS sending was made mandatory not to forget or skip none of the patients during the epicrisis writing procedure.
- Conditions
- Stents
- Keywords
- forgotten ureteral stents, SMS Reminder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Forgotten ureteral stents | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
A solution for medical and legal problems arising from forgotten ureteral stents: Reminder Short Message Service (SMS)
Primary Outcome Measure will be evaluated with;
- Number of the patients who admitted for stent removal will be compared with the patients who did not admit. So the effectivity of the SMS sending proram will be evaluated.
- The percentage of complication of forgotten ureteral stent will be calculated. And this rate will be compared with the previous rate of same department and the rates reported in the literature.
- Patient satisfaction surveys
- The time of the patients admitted. The data obtained from this study will be compared with previous data.
Measured: five months
Secondary outcomes (1)
SMS Reminder for Forgotten Ureteral Stents
Secondary, this practice can be prevalent in all hospitals at the our country.
Measured: one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jul 2010 (estimated)
- Study startMay 2010
- Primary completionOct 2010 (estimated)
- Study completionAug 2011 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StentsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 250 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Dicle University
- Sponsor type
- University, hospital or other
- Investigators
- Ahmet A Sancaktutar, Asist Prof., Principal investigator, Department of Urology, Dicle University School of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01172158
- Sponsor's protocol ID
- 1-Dicle University
- Acronym
- sms&FUS
- Status last verified
- Jul 2010
- First submitted
- 29 Jun 2010
- Last updated
- 29 Jul 2010
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 29 Jul 2010. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Solution for Medical and Legal Problems Arising From Forgotten Ureteral Stents: Reminder Short Message Service (SMS)
- ClinicalTrials.gov ID
- NCT01172158
- Acronym / sponsor ID
- sms&FUS / 1-Dicle University
- Conditions
- Stents
- Keywords
- forgotten ureteral stents, SMS Reminder
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 250 participants (estimated)
- Lead sponsor
- Dicle UniversityUniversity, hospital or other
- Study start
- May 2010
- Primary completion
- Oct 2010 (estimated)
- Study completion
- Aug 2011 (estimated)
- First posted
- 29 Jul 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Ureteral stents has become an indispensable instrument for urology practice as a result of widespread use of endourological interventions. Removal of stents could be sometimes neglected by patients or physicians. This omission may lead to legal and medical problems for urologists, health institutions and also for patients. In this study, the investigators offer a computer program providing two sided recall to prevent this nasty complication with sending automatic message by short message service (SMS) to both the patient and the urologist.
Detailed description
In this study, first an institutional subscription agreement was signed between our university and a mobile phone cell company which is supporting SMS sending program. In the second step, by making software plug-in to our hospital's patient follow up program, two programs were integrated. According to this integration, after stent insertion, in case of entering the numerical code corresponding of ''ureteral stent application'' procedure during the stage of epicrisis preparation, the patient follow up system warns the official recording the epicrisis to enter the stent removal time. Patient follow up system transfers this information to SMS sending program. After several weeks of the procedure, if the stent needs to be removed, the software automatically sends a warning message to the patient and the physician. If the patients attends to urology department and undergoes stent removal, the official enters the code of "endoscopic stent removal" to the patient follow-up program. Then the program stops to send warning message.
By the software plug-in to patient follow up program, SMS sending was made mandatory not to forget or skip none of the patients during the epicrisis writing procedure.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Forgotten ureteral stents | – | – |
Who may qualify
- Ages
- 1 year to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- First an institutional subscription agreement was signed between our university and a mobile phone cell company which is supporting SMS sending program. In the By making software plug-in to our hospital's patient follow up program, two programs were integrated. According to this integration, after stent insertion, in case of entering the numerical code corresponding of ''ureteral stent application'' procedure during the stage of epicrisis preparation, the patient follow up system warns the official recording the epicrisis to enter the stent removal time. Patient follow up system transfers this information to SMS sending program. After several weeks of the procedure, if the stent needs to be removed, the software automatically sends a warning message to the patient and the physician.
Key inclusion criteria (1 listed)
- Patients who had ureteral stent insertion.
Key exclusion criteria (1 listed)
- Patients who did not want SMS message from us or want to give cell phone number.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
A solution for medical and legal problems arising from forgotten ureteral stents: Reminder Short Message Service (SMS)
Time frame: five months
Primary Outcome Measure will be evaluated with; 1. Number of the patients who admitted for stent removal will be compared with the patients who did not admit. So the effectivity of the SMS sending proram will be evaluated. 2. The percentage of complication of forgotten ureteral stent will be calculated. And this rate will be compared with the previous rate of same department and the rates reported in the literature. 3. Patient satisfaction surveys 4. The time of the patients admitted. The data obtained from this study will be compared with previous data.
1 secondary outcome
SMS Reminder for Forgotten Ureteral Stents
Time frame: one year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jul 2010.
Related trials for Stents
Not yet recruiting
Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT)
Coronary In-stent Restenosis, Coronary Artery Disease
Active, not recruiting
Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization
Thrombosis, Arterial Occlusive Diseases
Recruiting
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Coronary Artery Disease
Not yet recruitingObservational study
Standardized Management of Esophageal Fistula in Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma (ESCC), Esophageal Fistula
RecruitingPhase 4
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Acute Coronary Syndromes, STEMI
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ahmet A Sancaktutar, Asist Prof. principal investigator
Department of Urology, Dicle University School of Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Stents, run by Dicle University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 29 Jul 2010. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
A solution for medical and legal problems arising from forgotten ureteral stents: Reminder Short Message Service (SMS) (time frame: five months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2010.